Two-Part Webinar Series
Technologies for analyzing proteome, metabolome, transcriptome, and epigenome data at both spatial and single-cell levels have come a long way. Taken together, these methods provide a holistic view of biological processes and systems and reveal potential therapeutic targets. However, combining and integrating data from these diverse modalities and platforms presents a significant challenge.
In this two-part GEN webinar series, our expert speakers Garry Nolan, PhD, (Part 1) will discuss MaxFuse, a new AI algorithm that provides reliable, fast, and cost-effective integration of spatial proteomic data with single-cell transcriptomic and epigenomic datasets. In part two, hear from Alexandro (Alex) Trevino, PhD, on how AI-powered algorithms within the Enable platform can facilitate comprehensive data storage, annotation, analysis, and search.
Webinar Part 2: Data Integration and Beyond: Creating and Leveraging Biological Atlases of Disease to Guide Drug Discovery
While recent advances in high-parameter spatial biology have contributed to a dramatic increase in volume and diversity of biological data, deriving actionable insights from these datasets remains a challenge due to a lack of accessible computational tools. In this webinar, Enable Medicine’s Alex Trevino, PhD, discusses how AI-powered algorithms within the Enable platform facilitate comprehensive data storage, annotation, analysis, and search.
Built on industry-leading generative AI and scientific expertise, Enable’s integrated data-to-insights platform helps scientists activate their biological data to power the next generation of life-saving diagnostics and therapeutics. With the Enable platform, access and map a vast array of structured biological data, and leverage cutting edge analysis and search to answer critical questions, from patient stratification to indication selection.
Interested in Part One: Bridging Spatial Genomics and Spatial Proteomics with MaxFuse, a New AI-Powered Algorithm – Watch Here>>
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…